Rita Nanda to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Rita Nanda has written about Drug Screening Assays, Antitumor.
Connection Strength
0.035
-
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients. Oncotarget. 2016 Jun 21; 7(25):38359-38366.
Score: 0.035